Statera Biopharma, Inc.

STABOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$7142

P/E Ratio—

52W High$0.0266

52W Low$0.0001

Avg Volume6K

Open$0.00

Beta-4.78

Overview

Statera Biopharma, Inc. (STAB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · STAB · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Statera Biopharma, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

STAB insider buying and selling by quarter

STAB insider selling · STAB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

915K457K0

2015 Q2

2015 Q3

2016 Q2

2016 Q3

2017 Q2

2018 Q3

2021 Q3

2022 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

STAB executive sell shares · STAB board member insider trading · STAB insider trading SEC filing

Showing 2 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jan 8, 2015	BROWN JULIA R Director	Award	62,500	$0.30	$19K	116,482	Form 4
Jan 8, 2015	Principi Anthony Director	Award	37,947	$0.30	$11K	52,419	Form 4

Date

Insider

Type

Value

Filing

Jan 8, 2015

BROWN JULIA R

Director

Award

62,500

$19K

Form 4

Jan 8, 2015

Principi Anthony

Director

Award

37,947

$11K

Form 4

BROWN JULIA R

Director

Award

Date

Jan 8

62,500

Price

$0.30

Value

$19K

View Form 4 on SEC.gov

Principi Anthony

Director

Award

Date

Jan 8

37,947

Price

$0.30

Value

$11K

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About STAB insider trading

STAB insider trades

Statera Biopharma, Inc. (STAB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including STAB. Over the past 12 months, 0 insiders have filed transactions with the SEC. STAB insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Statera Biopharma, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

STAB insider trading · 5 questions

The insiders of Statera Biopharma, Inc. (STAB) include executives and directors such as STAB, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

STAB board member insider tradingwho are STAB insidersSTAB insider rosterStatera Biopharma, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026